Medication info

Omese Tablet 20 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationExpired
Ingredient · strength
Esomeprazole Magnesium Dihydrate›Strength being verified
Manufacturer / importer
Sears Pharmaceuticals Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
28 tablets (14 tablets/Alu-Alu x 2)
Approval status
Expired

MFDS item code 201801434 · Approved 2018.03.30

This product's status changed to Expired on 2023.03.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders, gastrointestinal symptoms, and ulcers; prevention of ulcers; suppression of Helicobacter pylori
Who uses it
Adults · Children
Adult dosage
This drug should be swallowed with a liquid such as water and must not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis is not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg once daily may be administered as needed. As-needed administration to control ongoing symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for eradication of Helicobacter pylori Administer this drug 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (COX-2 nonselective or selective) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical studies lasting more than 4 weeks have not been conducted. 4) Patients requiring continuous use of nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into 2 doses. 6) Maintenance therapy following induction of prevention of rebleeding from gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding from gastric or duodenal ulcers with intravenous administration. 4. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this drug to patients with severe renal impairment. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not exceed a dose of 20 mg of this drug. 6. Elderly patients: No dose adjustment is necessary.
Children's dosage
2. Adolescents 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis is not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg once daily may be administered as needed. As-needed administration to control ongoing symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 3. Children under 12 years: There is no experience with administration of this drug to children under 12 years.

Ingredients

Manufacturer
Sears Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders, gastrointestinal symptoms, and ulcers; prevention of ulcers; suppression of Helicobacter pylori

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • Helicobacter pylori positive duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for the treatment of gastroesophageal reflux disease, particularly erosive esophagitis, and for long-term maintenance therapy to prevent recurrence. It also helps in relieving symptoms of gastroesophageal reflux disease without esophagitis. It is used in combination with antibiotics for eradication of Helicobacter pylori for the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers. It is also effective for the treatment of upper gastrointestinal symptoms associated with non-steroidal anti-inflammatory drug use, as well as for the prevention of gastric ulcers and duodenal ulcers. This medication is also applicable for the treatment of Zollinger-Ellison syndrome and for maintenance therapy to prevent rebleeding of gastric or duodenal ulcers. Overall, it is widely used for the treatment of various symptoms and diseases related to gastrointestinal disorders.

Dosage and Administration

Adult dosage

This drug should be swallowed with a liquid such as water and must not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis is not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg once daily may be administered as needed. As-needed administration to control ongoing symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for eradication of Helicobacter pylori Administer this drug 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (COX-2 nonselective or selective) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical studies lasting more than 4 weeks have not been conducted. 4) Patients requiring continuous use of nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into 2 doses. 6) Maintenance therapy following induction of prevention of rebleeding from gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding from gastric or duodenal ulcers with intravenous administration. 4. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this drug to patients with severe renal impairment. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not exceed a dose of 20 mg of this drug. 6. Elderly patients: No dose adjustment is necessary.

Children's dosage

2. Adolescents 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis is not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg once daily may be administered as needed. As-needed administration to control ongoing symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 3. Children under 12 years: There is no experience with administration of this drug to children under 12 years.

Precautions

This medication should not be used in certain patients. It should not be taken by individuals who are allergic to this drug or its ingredients, or have a history of hypersensitivity to benzimidazole-class medications. Additionally, patients who are allergic to penicillin antibiotics or macrolide antibiotics should not use this medication in combination. In particular, there is a risk of side effects when used in conjunction with certain heart-related medications or antivirals, so it should be avoided. It is also safer for breastfeeding women not to take this medication. This medication can cause various adverse reactions. For example, it may result in decreased blood cell counts, abnormal immune responses, electrolyte imbalances, neurological symptoms, digestive issues, etc. Particularly, hypomagnesemia can cause serious side effects and requires attention. Reports of skin rashes, severe allergic reactions, liver dysfunction, muscle issues have also been noted. If any of these symptoms occur, consult a healthcare provider immediately. Long-term use of this medication can mask malignancy symptoms or delay diagnosis, so consult a specialist if suspicious symptoms arise. Regular check-ups to monitor health status are important for those who take this medication for more than one year. Furthermore, this medication may interact with other drugs, so always consult a doctor when symptoms change or when taking other medications. This medication may reduce gastric acid secretion and lead to an increase in the number of bacteria in the gastrointestinal tract, which may slightly increase the risk of infections. Hospitalized patients or those with weakened immunity need to exercise particular caution, and if diarrhea persists, they should visit a hospital immediately. Long-term use may increase the risk of fractures, so patients at risk of osteoporosis should receive proper management, including bone density testing per the doctor's instructions. Additionally, this medication contains sugars, so patients with certain metabolic disorders of sugars should not take it. This medication can interact with multiple drugs, so if taking other medications, always inform healthcare professionals. Particularly when used with anticoagulants, anticonvulsants, antidepressants, or antivirals, blood concentration changes and side effect risks should be monitored. The data on the safety of this medication during pregnancy is limited, so pregnant women should consult a doctor before taking it. Breastfeeding women are also advised not to take this medication. There are no specific antidotes in case of overdose, so treatment should be symptomatic and general supportive care is necessary. Keep this medication out of reach of children and do not transfer it to another container.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternum pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, lethargy, pain, rigidity, peripheral edema, flushing, hypertension, tachycardia, thyroid adenoma, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal hemorrhage, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, elevated serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, spasms, fibromyalgia syndrome, hernia, polymyalgia rheumatica, arthralgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, anxiety, sensory loss, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorders, tremors, dizziness, visual field loss, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, abnormal olfaction, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infections, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp, nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric adenomatous polyp, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The refrigerated storage temperature should be maintained between 1 and 30 degrees Celsius. Proper storage will maintain the effectiveness and safety of the medication for a long time.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

28 tablets (14 tablets/Alu-Alu x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.